Mariana Oncology

As we recognize National Patient Safety Awareness Week, we’re reminded of the critical importance of developing therapies that prioritize patient safety while maximizing effectiveness. We are committed to developing safer, more effective treatment options with the aim of enabling patients to live their lives without compromise throughout treatment and beyond. Here’s to continuing our work in prioritizing patient safety and transforming the experience of cancer treatment with precise radioligand therapies. #NationalPatientSafetyAwarenessWeek #PSAW #PatientSafety

We are proud to announce that Frederic Zecri has been appointed as Mariana's Chief Scientific Officer and Site Head. With his extensive experience in drug discovery and collaborative leadership at Novartis we are confident that Fred will play a pivotal role in accelerating the discovery and development of precision radioligand therapies and driving excellence in radioligand therapy innovation to deliver potentially transformative treatments to patients. Please join us in welcoming Fred to the Mariana Oncology team!

Today, on National Caregiver's Day, we thank those who provide unwavering support to individuals living with cancer. Caregivers are an essential part of the cancer journey, and your commitment inspires us as we advance radioligand therapies with the potential to change the experience of cancer treatment. #NationalCaregiversDay #Oncology

Radioligand therapies (RLTs) have the potential to fundamentally transform the way we treat cancer. Our lead program targets DLL3, a cell surface protein widely expressed across a range of cancers, with limited expression in healthy cells. This selective expression unlocks opportunities to deliver powerful therapeutic payloads directly to the tumor while minimizing effects on other parts of the body. #RLT #RadioligandTherapy #Oncology

Today, on World Cancer Day, we reflect on the millions of lives touched by cancer. Every diagnosis represents a unique journey and a unique story of resilience, healing, and strength. We are inspired by these stories and remain committed to pioneering precisely targeted radioligand therapies with the potential to address cancers of high unmet need. Let’s work together to spread knowledge, encourage early screening, and push the boundaries of science to transform lives of people living with cancer. Learn more: https://brnw.ch/21wQsMq #WorldCancerDay

This #MLKDay, we honor the profound impact of Dr. Martin Luther King Jr. and his unwavering commitment to equality, justice, and hope. In the words of Dr. King, “Faith is taking the first step even when you don’t see the whole staircase.” Innovation is rarely easy, and filled with uncertainty, but just as Dr. King showed us, it is through courage and conviction that change happens. #Oncology

The New Year is an opportunity to cast our vision forward to the opportunities 2025 will bring. As Mariana embarks on the New Year, we look forward to continuing our mission to usher in a new generation of precise radioligand therapies with the aim of transforming the experience of treatment for patients. Learn more about our innovative approach to #RLT development: https://brnw.ch/21wPQ6r #Oncology #RadioligandTherapy

Happy Holidays from all of us at Mariana Oncology! As we celebrate the season of joy and reflection, we wanted to extend our heartfelt gratitude to our partners and team members. May this holiday season bring you peace, happiness, and time with loved ones. Here’s to a healthy and prosperous New Year ahead!

Our approach to radioligand therapy (RLT) development is guided by a deep understanding of tumor target biology. We select targets that offer potential to address a range of cancers and tailor our drug design criteria for optimal target engagement and precise delivery of radioactive payloads to tumor sites, while minimizing impact on healthy tissues. Learn more about our approach to RLT design and development: https://brnw.ch/21wPlgv

We’ve made it to the final tribal council, and we’re taking home the NEVY Award for Powerhouse Life Science Company of the Year! This achievement is a true reflection of the passion, hard work, and vision of our incredible team. We’re so proud to be recognized for our contributions to biotech, and we’re even more excited for the future as we continue to innovate and improve healthcare solutions. A huge thank you to the New England Venture Capital Association (NEVCA), our partners, and everyone who has supported us along the way. #NEVYSurvivor #NEVCA #NEVYs24